Buy these 40 smaller stocks with up to 106% upside despite higher interest rates: UBS
Small- and mid-sized companies have consistently trailed large caps, but UBS believes that may change. Here are 40 top ...
UBS sees potential in Argentina stock market following fiscal milestone
UBS Financial Services noted that Argentina has achieved a significant economic turnaround, eliminating a fiscal deficit that ...
The rally can keep going, we are interested in AI and power generation stocks: UBS' Mark Haefele
Mark Haefele from UBS Global Wealth Management shares his outlook on the U.S. economy and market for 2025 and says he expects ...
UBS’s stock hit its highest level in 16 years. The good news is the bank is about to get fined hundreds of millions of dollars.
UBS stock reached a new 16-year high after the Wall Street Journal said the bank is about to get fined hundreds of millions ...
Molson Coors price target lowered to $58 from $60 at UBS
UBS analyst Peter Grom lowered the firm’s price target on Molson Coors (TAP) to $58 from $60 and keeps a Neutral rating on the shares.
Why UBS Group (UBS) is Skyrocketing in 2025?
UBS Group (NYSE:UBS) is a Swiss financial services company. It is the world’s largest wealth manager. The stock has been ...
UBS on Continental stock: 'We are buyers now'
Investing.com -- UBS analysts have reaffirmed their bullish stance on Continental (ETR: CONG) stock, emphasizing the ...
USD/INR: UBS recommends shorting India's rupee
Over the past month, Indian stocks have seen nearly $500 billion wiped off their market value. This marks the worst start to ...
EchoStar price target raised to $28 from $15 at UBS
UBS raised the firm’s price target on EchoStar (SATS) to $28 from $15 and keeps a Neutral rating on the shares. Efforts to scale the wireless ...
Morningstar2d
UBS Group AG UBS N
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone'
Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...
Underlying trends remain favorable for equities: UBS
The choppy start to 2025 for the stock market has not been caused by any fundamentally negative economic news, and underlying trends remain favorable for equities, according to Solita Marcelli, chief ...